PHILADELPHIA, Nov. 14, 2024 /PRNewswire/ — Health Union, the leading digital health company building online communities that empower people to live better with health challenges, has launched seven new communities over the past year, expanding its efforts to provide information, resources, and support for people living with mental health conditions and cardiometabolic conditions.
New health communities include four focused on mental health — Bipolar.Mental-Health-Community.com, Depression.Mental-Health-Community.com, Postpartum.Mental-Health-Community.com, and Schizophrenia.Mental-Health-Community.com — as well as Obesity.net, CardiovascularDisease.net, and NASHDisease.net. Each community provides valuable resources and support where patients and caregivers can connect, share their experiences, and access trusted information.
“Every person living with a health condition deserves a place to feel understood, supported, and empowered,” said Olivier Chateau, co-founder and CEO of Health Union. “By expanding our community footprint, we’re not only addressing more diverse health needs but also breaking down barriers that prevent people from getting the support they need. Our goal remains to transform the experience of living with challenging health conditions by bringing people together and providing a trusted platform for shared knowledge and connection.”
With these additions, Health Union strengthens its commitment to fostering connections and improving the quality of life for individuals affected by a diverse range of health challenges, including conditions that can be stigmatizing, underrecognized, or misunderstood. Each community is tailored to meet the unique needs of its members, offering a safe environment where people can find support, learn from others’ experiences, and navigate their health journeys together.
Each of the new communities combines expert-reviewed content with peer support, featuring polls, forums, and other tools designed to address condition-specific needs and empower people in their health journeys:
For pharmaceutical and healthcare industry partners, these communities present a unique opportunity to align messages with highly engaged, qualified audiences, enabling advertisers to reach patients who may benefit from their treatments. By connecting brands with people actively managing their health, Health Union fosters meaningful partnerships that drive improved outcomes for both business partners and the patients they serve. Learn more about how pharmaceutical advertisers can drive awareness, engagement, and conversion results by leveraging the power of Health Union’s condition-specific communities here: health-union.com/business-solutions
About Health Union
Health Union is the proven industry leader in condition-specific, online health community and patient engagement. The company reaches millions of people through the largest network of online health communities (e.g., Migraine.com, MultipleSclerosis.net, LungCancer.net) and health leaders — addressing virtually every condition and providing patients and caregivers with the information, connection, and support they need to live better with challenging health conditions. For more than a decade, Health Union has been transforming the way pharmaceutical and healthcare brands engage with people, enabling transparent, innovative opportunities to gain insight and empower action through advertising, marketing research, and clinical trial solutions for the healthcare industry.
SOURCE Health Union
CTC PD-L1 assay enables longitudinal monitoring of PD-L1 status in lung cancer patients and may…
RESULTS FROM WORK TO DEVELOP A PARSORTIX-BASED Her2 assay KIT SHOWCASED AT INTERNATIONAL LIQUID BIOPSY…
Learn How at an Exclusive Webinar on Nov. 20th Hosted by Medical Economics and Specialdocs …
A Transformative Virtual Event Celebrates Unity, Hope, and Global Peace, Featuring Renowned Guests and Visionary…
Launched non-medical sales in Ohio with initial sales accounting for 38% of total state level…
Vancouver, British Columbia--(Newsfile Corp. - November 14, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…